PlainPharmaWatch

CMS Open Payments · Program Year 2024

Occlutech US LLC

Occlutech US LLC reported $1,155,855.11 across General Payments, Research, and Ownership to 120 physicians and teaching hospitals across 120 transactions.

See the rankings → How this is sourced
$1.2M
All-tracks total
120
Transactions
120
Recipients
#588
of 1,925 companies

Occlutech US LLC reported $1,155,855.11 across all CMS Open Payments tracks (General + Research + Ownership) to 120 physicians and teaching hospitals in Program Year 2024 - ranking #588 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,155,855.11, averaging $9.6K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer occlutech-us-llc Occlutech US LLC

$1.2M · #588/1,925 · 0.0% industry · PY2024

  • TOT $1.2M
  • RANK #588
  • SHARE 0.0%
  • TXN 120
  • RCP 120
  • CAT 1
  • GEN $1.2M
  • TOP1 25.4%
  • PY 2024

Volume peers

Nearest volume peer: Noah Medical Corporation ($1.2M)

New Wave Endo-Surgical Corp.$1.2MRevance Therapeutics, Inc.$1.2MOcclutech US LLC (this)$1.2MNoah Medical Corporation$1.2MOssio Ltd$1.1M
All-tracks payment totals near Occlutech US LLC (CMS Open Payments PY2024)

Occlutech US LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for Occlutech US LLC

Averaging $9.6K per transaction and $9.6K per recipient, Occlutech US LLC's Program Year 2024 total comes to $1,155,855.11 across 120 transactions and 120 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #588 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 1 general-payment categories charted below, "Grant" is the largest at $1.2M across 120 transactions, 100.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 1 types of general payments, Occlutech US LLC's largest category was "Grant" at $1.2M - 100.0% of General Payments.

How Occlutech US LLC divides its payments

General-payment categories, ordered by reported total

1. Grant$1.2M
Payment Type Amount Transactions
Grant $1.2M 120

Recipient Concentration in General Payments

The five largest recipient relationships account for $584,146.58 (50.5%) of $1,155,855.11 in this company's General Payments records across 29 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Occlutech US LLC

The five named recipients with the highest reported General Payments from this company

Baystate Medical Center$294.0KTufts Medical Center$80.3KMassachusetts General Hospit…$78.7KThe Nebraska Medical Center$76.3KOsf Heart Of Mary Medical Ce…$54.8K
  1. 1

    Baystate Medical Center

    $293,981.60 across 5 reported transactions

  2. 2

    Tufts Medical Center

    $80,347.50 across 8 reported transactions

  3. 3

    Massachusetts General Hospital

    $78,726.00 across 9 reported transactions

  4. 4

    The Nebraska Medical Center

    $76,262.48 across 6 reported transactions

  5. 5

    Osf Heart Of Mary Medical Center

    $54,829.00 across 6 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Occlutech US LLC's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Occlutech US LLC.

Cytyc Surgical Products, LLC

HHI 961

BioXcel Therapeutics, Inc.

HHI 958

Spinefrontier, Inc.

HHI 958

Ge Healthcare

HHI 966

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Occlutech US LLC.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Occlutech US LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.